Dr. Díaz Pinillos's testosterone pellet claims, fact-checked

What did @drjuliodiazpinillos actually say?

Honestly, the transcript here is a mess. The audio appears to have been auto-transcribed from Spanish into garbled English, producing phrases like "Philech did the testosterone, who took it as the mission" and references to "mother-in-law" taking "territories." None of that reflects coherent medical claims. What we can work with is the caption, which makes the substantive assertion: testosterone pellets are "small implants inserted under the skin" that "release testosterone slowly and constantly for several months." That part is real and worth examining.

The hashtags also tell a story: #juventud (youth), #testosterona, and #ginecologia suggest this video frames pellets as a vitality-restoring, age-reversing intervention aimed at a broad audience, not just patients with diagnosed hypogonadism. That framing matters, because it shapes who shows up asking for pellets and why.

Does the science back this up?

The basic pharmacology of pellets is accurate. The marketing language around "recovering vitality" is where things get slippery. Pellets do provide sustained testosterone delivery, but the evidence base is thinner than proponents admit.

A 2019 systematic review by Pastuszak et al. in the journal Sexual Medicine Reviews found that while pellets maintain relatively stable serum testosterone levels over three to six months, the data on clinical outcomes, meaning actual improvements in energy, libido, mood, and body composition, remain limited compared to injectable or transdermal formulations. The review noted that most pellet studies are small, industry-adjacent, and lack long-term safety follow-up.

Pellet dosing is also less adjustable than other delivery methods. If a patient is over-dosed or has an unexpected reaction, you cannot simply stop applying a gel or skip an injection. The pellet keeps releasing. A 2017 paper by Bhattacharya et al. in Andrology documented supraphysiologic testosterone levels in a subset of pellet patients, with polycythemia as a documented adverse event. That is not a minor footnote.

What did they get wrong (or right)?

Credit where it is due: the caption's core description of pellets as subcutaneous implants releasing testosterone slowly over several months is accurate. That is what pellets do, mechanically speaking. No argument there.

What the video gets wrong, or at least dangerously incomplete, is the framing. "Recover your vitality" is not a clinical indication. It is marketing. The actual approved indication for testosterone therapy is hypogonadism, a documented deficiency confirmed by lab values and symptoms, not a general sense of feeling less energetic than you did at 25.

The hashtag #juventud (youth) is particularly telling. It implies testosterone pellets are an anti-aging tool. The Endocrine Society's 2018 clinical practice guideline explicitly advises against prescribing testosterone solely to address age-related decline in otherwise healthy men without confirmed hypogonadism. Cardiovascular risk signals, while debated, have not been resolved. The TRAVERSE trial, published in 2023 in the New England Journal of Medicine (Lincoff et al.), found testosterone therapy did not significantly increase major cardiovascular events in men with hypogonadism and high cardiovascular risk, but this applies to a specific diagnosed population, not a general wellness audience.

What should you actually know?

Testosterone pellets are a legitimate delivery method for patients who have documented hypogonadism, have discussed the risks with a qualified provider, and prefer a long-acting option over weekly injections or daily gel application. For that specific patient, pellets are a reasonable clinical choice.

They are not a universal vitality upgrade. Side effects include infection at the insertion site, pellet extrusion, supraphysiologic dosing with no easy correction, and polycythemia. Women, who are increasingly targeted by pellet marketing, face additional risks including irreversible virilization at high doses, a concern raised in a 2020 commentary by Glaser and Dimitrakakis in Maturitas.

If a video on social media leads you to a clinic offering pellets without a baseline hormone panel, a symptom assessment, and a clear conversation about alternatives, that is a red flag. The delivery method is not the first decision. Whether you actually need testosterone therapy at all is.

• Pellets are FDA-regulated as a drug delivery device, but the testosterone compound inside is often compounded, not an FDA-approved finished drug product. That is a meaningful regulatory distinction.
• Compounded testosterone pellets are not equivalent to FDA-approved testosterone products. Do not let anyone tell you otherwise.
• If you are considering any testosterone therapy, start with a lab draw, not a TikTok video.